Epithelial-mesenchymal transition (EMT) markers have prognostic impact in multiple primary oral squamous cell carcinoma
Multiple primary tumors can occur in up to 35 % of the patients with head and neck cancer, however its clinicopathological features remain controversial. Deregulation of epithelial-mesenchymal transition (EMT) signaling has been associated with aggressive malignancies and tumor progression to metast...
Gespeichert in:
Veröffentlicht in: | Clinical & experimental metastasis 2015-01, Vol.32 (1), p.55-63 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Multiple primary tumors can occur in up to 35 % of the patients with head and neck cancer, however its clinicopathological features remain controversial. Deregulation of epithelial-mesenchymal transition (EMT) signaling has been associated with aggressive malignancies and tumor progression to metastasis in several cancer types. This study is the first to explore EMT process in multiple primary oral squamous cell carcinomas (OSCC). Immunohistochemical analysis of E-cadherin, catenin (α, β, and γ), APC, collagen IV, Ki-67, cyclin D1, and CD44 were performed in a tissue microarray containing multiple representative areas from 102 OSCC patients followed-up by at least 10 years. Results were analysed in relation to clinicopathological characteristics and survival rates in patients presenting multiple primary tumors
versus
patients without second primary tumors or metastatic disease. Significant association was observed among multiple OSCCs and protein expression of E-cadherin (
P
= 0.002), β-catenin (
P
= 0.047), APC (
P
= 0.017), and cyclin D1 (
P
= 0.001) as well as between lymph nodes metastasis and Ki-67 staining (
P
= 0.021). OSCCs presenting vascular embolization were associated with negative β-catenin membrane expression (
P
= 0.050). There was a significantly lower survival probability for patients with multiple OSCC (log-rank test,
P
|
---|---|
ISSN: | 0262-0898 1573-7276 |
DOI: | 10.1007/s10585-014-9690-1 |